| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on April 24, 2007
Accepted on August 27, 2007
Service of Bone Diseases, WHO Collaborating Center for Osteoporosis Prevention, Department of Rehabilitation and Geriatrics, University Hospital of Geneva, Switzerland
* To whom correspondence should be addressed. E-mail: serge.ferrari{at}medecine.unige.ch.
Objective: The contribution of leptin to bone mass acquisition in humans remains unclear. We investigated the association of the Gln223Arg polymorphism in the leptin receptor gene (LEPR) with bone mineral content (BMC) and areal bone mineral density (aBMD) in pre-pubertal boys, and LEPR interaction with vitamin D receptor (VDR) genotypes (Bsm1 and Fok1).
Design: In a cross-sectional design with a longitudinal follow-up, DXA measurements at the lumbar spine, hip, femoral diaphysis, and radius were performed at baseline (mean age 7.4 ± 0.4 yrs) and two years later in 222 healthy Caucasian males.
Results: LEPR genotypes were significantly associated with baseline BMC at the hip (P=0.017), femur diaphysis (P=0.019) and radius (P=0.007), with height (P=0.041) as well as with physical activity (P=0.016). Associations with height and BMC at femur diaphysis and radius remained significant after two years. Significant differences in two-year bone mass gain at the spine and femur neck were also found among LEPR genotypes. In contrast, adjusting BMC for projected bone area (aBMD) and/or weight, height and physical activity, resulted in a weak association only at the femur (P=0.014–0.054). VDR polymorphisms were not associated with BMC/aBMD, but significant interactions occurred between VDR Fok1 and LEPR genotypes.
Conclusions: The LEPR Gln223Arg polymorphism was associated with bone mass in growing boys. The association, however, was markedly dependent on bone area, body size and physical activity, in addition to VDR genetic variation, suggesting that the leptin system may modulate bone mass in humans mostly through indirect mechanisms.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |